Vasoconstrictor Agents - Therapeutic use
Research News and Information

Monday, November 23, 2009

Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.

29 Sep 2009 BACKGROUND: At present, terlipressin is predominantly used for the management of bleeding gastric and esophageal varices, as well as hepato-renal syndrome secondary to liver cirrhosis. Owing to its high and relatively selective affinity to vascular ... Read more...

Pulmonary arterial hypertension in human immunodeficiency virus infection.

30 Aug 2009 Because of the improvement in survival rates of human immunodeficiency virus (HIV)-infected patients after the introduction of combined antiretroviral therapy, pulmonary arterial hypertension (PAH) has become an important cause of morbidity. As the ... Read more...

The management of severe sepsis and septic shock.

30 Aug 2009 The diagnosis and management of severe sepsis and septic shock is a complex and dynamic process. Newer evidence-based interventions are constantly being developed and implemented with the purpose of improving morbidity and mortality. Current ... Read more...

Latest indexed articles for 'Vasoconstrictor Agents - Therapeutic use'

These are the very latest articles for this heading:

• Unpublished clinical trials with sumatriptan. 29 Oct 2009
• Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock. 29 Sep 2009
• Renal failure in cirrhosis. 22 Sep 2009
• [Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding] 31 Aug 2009
• Pulmonary arterial hypertension in human immunodeficiency virus infection. 30 Aug 2009
• Terlipressin vs. octreotide in bleeding esophageal varices. 30 Aug 2009
• The management of severe sepsis and septic shock. 30 Aug 2009
• Prevention of early variceal rebleeding adding banding to terlipressin therapy. 30 Aug 2009
• Bupivacaine-induced cardiac arrest: fat is good-is epinephrine really bad? 30 Aug 2009
• Burden of proof. 30 Aug 2009
• A 56-year-old man in the intensive care unit with a complex acid-base disturbance. 30 Aug 2009
• What can be learned from the history of recurrence in migraine? A comment. 23 Aug 2009
• A retrospective comparison of anesthetic management of robot-assisted laparoscopic radical prostatectomy versus radical retropubic prostatectomy. 20 Aug 2009
• Hypotension and shock in the preterm neonate. 30 Jul 2009
• Refractory hypotension and ECG changes in a case of nicorandil and lisinopril overdose and role of vasopressor in management. 30 Jul 2009
• Calcific embolus causing subarachnoid hemorrhage. 19 Jul 2009
• Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. 14 Jul 2009
• Pronouncing brain death: contemporary practice and safety of the apnea test. 12 Jul 2009
• Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? 29 Jun 2009
• Analysis of baroreflex sensitivity during undulation pump ventricular assist device support. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Vasoconstrictor Agents'

Definition: Drugs used to cause constriction of the blood vessels.

Registry Number: 0

Descriptor UI: D014662

Alternative terms: Vasoconstrictor Agents; Agents, Vasoconstrictor; Vasoconstrictor Drugs; Drugs, Vasoconstrictor; Vasoconstrictors; Vasoactive Agonists; Agonists, Vasoactive; Vasopressor Agents; Agents, Vasopressor;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.954.411.793;

History Note: 67(65)

Technical Notes: consider also VASOMOTOR SYSTEM /drug eff